PMX 205

Known as: PMX-205, PMX205 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1989-2018
012319892018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
This study investigated the role of the alternative receptor for complement activation fragment C5a, C5aR2, in secondary… (More)
Is this relevant?
2017
2017
BACKGROUND AND PURPOSE Amyotrophic lateral sclerosis (ALS) is a fatal and rapidly progressing motor neuron disease without… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2014
2014
Allergic asthma is a chronic inflammatory airway disease arising from an aberrant immune response following exposure to… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2013
2013
BACKGROUND AND PURPOSE Anti-complement therapies have not been advanced for treating the inflammatory bowel diseases (IBDs… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2011
2011
BACKGROUND AND OBJECTIVE The complement activation product 5a (C5a) is a potent mediator of the innate immune response to… (More)
Is this relevant?
2010
2010
Alzheimer's disease (AD), a progressive neurodegenerative disease characterized by the accumulation of amyloid-beta protein and… (More)
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Alzheimer's disease (AD) is an age-related dementia, characterized by amyloid plaques, neurofibrillary tangles, neuroinflammation… (More)
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Complement activation products are elevated in the cerebrospinal fluid and spinal cord of patients with amyotrophic lateral… (More)
Is this relevant?
2006
2006
Overproduction or underregulation of the proinflammatory complement component C5a has been implicated in numerous immune and… (More)
Is this relevant?
2002
2002
This study evaluates the effect of direct hemoperfusion (DHP) using polymyxin B-immobilized fibers (PMX-F) as an extracorporeal… (More)
Is this relevant?